Health TidingsTecvayli Plus Talvey Significantly Improves Survival in Phase 3 Multiple My... Tecvayli Plus Talvey Significantly Improves Survival in Phase 3 Multiple My... Read Post »
New Drug ApprovalAstraZeneca’s Etcamah Wins EU Approval for ESR1-Mutated HR-Positive Advan... AstraZeneca’s Etcamah Wins EU Approval for ESR1-Mutated HR-Positive Advan... Read Post »
New Drug ApprovalChina Approves Takeda’s ORZEYFUL for Narcolepsy Type 1 China Approves Takeda’s ORZEYFUL for Narcolepsy Type 1 Read Post »
Health TidingsCrystalys Therapeutics Raises $130 Million to Advance Phase 3 Development o... Crystalys Therapeutics Raises $130 Million to Advance Phase 3 Development o... Read Post »
Clinical TrialsZydus Advances Desidustat into Phase 3 Trial for Sickle Cell Disease Anemia... Zydus Advances Desidustat into Phase 3 Trial for Sickle Cell Disease Anemia... Read Post »
Clinical TrialsRetatrutide Shows Strong Weight Loss in Adults With Obesity and Type 2 Diab... Retatrutide Shows Strong Weight Loss in Adults With Obesity and Type 2 Diab... Read Post »
Health TidingsNHS England Introduces Fampridine for Walking Difficulties in Multiple Scle... NHS England Introduces Fampridine for Walking Difficulties in Multiple Scle... Read Post »
Mergers & AcquisitionsArcus and Summit Launch Casdatifan–Ivonescimab Trial in Metastatic Kidney... Arcus and Summit Launch Casdatifan–Ivonescimab Trial in Metastatic Kidney... Read Post »
ResearchReview Supports Bradykinin B2 Receptor as a Validated Target in Bradykinin-... Review Supports Bradykinin B2 Receptor as a Validated Target in Bradykinin-... Read Post »
Clinical TrialsFDA Accepts Daraxonrasib NDA for Previously Treated Metastatic Pancreatic C... FDA Accepts Daraxonrasib NDA for Previously Treated Metastatic Pancreatic C... Read Post »
Health TidingsPositive TALAPRO-3 Data Earn FDA Priority Review for TALZENNA Plus XTANDI Positive TALAPRO-3 Data Earn FDA Priority Review for TALZENNA Plus XTANDI Read Post »
New Drug ApprovalFDA Approves GSK’s Jideytro for Previously Treated ROS1-Positive Adva... FDA Approves GSK’s Jideytro for Previously Treated ROS1-Positive Adva... Read Post »
Health TidingsBridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1 BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1 Read Post »
Health TidingsFDA Grants Orphan Drug Status to Affinia’s AFTX-201 for BAG3-Associat... FDA Grants Orphan Drug Status to Affinia’s AFTX-201 for BAG3-Associat... Read Post »
Health TidingsRadiopharm’s RAD101 PET Imaging Meets Phase 2b Primary Endpoint in Re... Radiopharm’s RAD101 PET Imaging Meets Phase 2b Primary Endpoint in Re... Read Post »
Health TidingsPeer-Reviewed Phase 1 Data Support TLX591-Tx as a Differentiated PSMA-Targe... Peer-Reviewed Phase 1 Data Support TLX591-Tx as a Differentiated PSMA-Targe... Read Post »
Health TidingsRibo’s Vortosiran Cuts Factor XI Activity by 92% in Phase 2a Coronary... Ribo’s Vortosiran Cuts Factor XI Activity by 92% in Phase 2a Coronary... Read Post »
Clinical TrialsArrowhead’s Phase 3 SHASTA Trials Show Plozasiran Cuts Triglycerides ... Arrowhead’s Phase 3 SHASTA Trials Show Plozasiran Cuts Triglycerides ... Read Post »
Clinical TrialsCelldex Ends Barzolvolimab Development in Prurigo Nodularis After Phase 2 T... Celldex Ends Barzolvolimab Development in Prurigo Nodularis After Phase 2 T... Read Post »
Clinical TrialsSummit Therapeutics Reports Updated Overall Survival Analysis from Phase II... Summit Therapeutics Reports Updated Overall Survival Analysis from Phase II... Read Post »
GenericsFDA Expands Glenmark’s RYALTRIS Use for Seasonal Allergic Rhinitis in... FDA Expands Glenmark’s RYALTRIS Use for Seasonal Allergic Rhinitis in... Read Post »
Health TidingsIslatravir/Lenacapavir Maintains Virological Suppression Through 48 Weeks i... Islatravir/Lenacapavir Maintains Virological Suppression Through 48 Weeks i... Read Post »
New Drug ApprovalMHRA Approves World’s First Lower-Carbon Beclometasone Inhalers for Asthm... MHRA Approves World’s First Lower-Carbon Beclometasone Inhalers for Asthm... Read Post »
Clinical TrialsActinogen’s Xanamem Shows Antidepressant Benefit in Phase 2 MDD Trial Actinogen’s Xanamem Shows Antidepressant Benefit in Phase 2 MDD Trial Read Post »
Clinical TrialsGilead to Present Long-Term Lenacapavir, ISLEND and HIV Pipeline Data at AI... Gilead to Present Long-Term Lenacapavir, ISLEND and HIV Pipeline Data at AI... Read Post »
Health TidingsTempest Advances TPST-4003 Toward First Clinical Evaluation of In Vivo CAR-... Tempest Advances TPST-4003 Toward First Clinical Evaluation of In Vivo CAR-... Read Post »
Regulatory & Health PolicyAlpha Tau Reports 100% Response Rate with Alpha DaRT Plus Keytruda in Early... Alpha Tau Reports 100% Response Rate with Alpha DaRT Plus Keytruda in Early... Read Post »
Health TidingsIMUNON Reports Positive Phase 2 Translational Data Supporting IMNN-001 in A... IMUNON Reports Positive Phase 2 Translational Data Supporting IMNN-001 in A... Read Post »
Medical DevicesEnvoy Medical Completes Three-Month Milestone in Acclaim Cochlear Implant T... Envoy Medical Completes Three-Month Milestone in Acclaim Cochlear Implant T... Read Post »
Health TidingsNOUS-209 Re-Treatment Boosts Durable T-Cell Responses in Lynch Syndrome NOUS-209 Re-Treatment Boosts Durable T-Cell Responses in Lynch Syndrome Read Post »
Health TidingsPhanes Advances Spevatamig-KYTRUDA in First-Line Biliary Tract Cancer with ... Phanes Advances Spevatamig-KYTRUDA in First-Line Biliary Tract Cancer with ... Read Post »
Clinical TrialsAkagera Reports Positive Data for Long-Acting AKG-100 in Drug-Resistant Tub... Akagera Reports Positive Data for Long-Acting AKG-100 in Drug-Resistant Tub... Read Post »
Clinical TrialsSamsung Bioepis and Harrow Present Positive Real-World Data for BYOOVIZ® B... Samsung Bioepis and Harrow Present Positive Real-World Data for BYOOVIZ® B... Read Post »
Clinical TrialsAgios Shifts PK Activation Strategy to Mitapivat After Tebapivat Falls Shor... Agios Shifts PK Activation Strategy to Mitapivat After Tebapivat Falls Shor... Read Post »
Health TidingsFDA Grants Fast Track Designation to Oncolytics’s Pelareorep FDA Grants Fast Track Designation to Oncolytics’s Pelareorep Read Post »
Clinical TrialsSura-vec Maintains Long-Term Vision Benefits in Wet AMD and Diabetic Retino... Sura-vec Maintains Long-Term Vision Benefits in Wet AMD and Diabetic Retino... Read Post »
Health Tidings Mergers & AcquisitionsHalozyme and Incyte Partner to Advance Subcutaneous INCA033989 for mutCALR-... Halozyme and Incyte Partner to Advance Subcutaneous INCA033989 for mutCALR-... Read Post »
Clinical TrialsBiohaven Unveils Early Phase 1 BHV-1530 Data and Regeneron Partnership Biohaven Unveils Early Phase 1 BHV-1530 Data and Regeneron Partnership Read Post »
Clinical TrialsGreenwich Expands Phase III FLAMINGO 01 Trial After DSMB Support for GLSI 1... Greenwich Expands Phase III FLAMINGO 01 Trial After DSMB Support for GLSI 1... Read Post »
Health TidingsFDA Grants Priority Review to Dyne’s z-Rostudirsen for DMD FDA Grants Priority Review to Dyne’s z-Rostudirsen for DMD Read Post »
Health TidingsNamodenoson Shows Durable Disease Control in Advanced Pancreatic Cancer Namodenoson Shows Durable Disease Control in Advanced Pancreatic Cancer Read Post »
Health TidingsDuvakitug Improves Clinical Remission in Ulcerative Colitis Trial Duvakitug Improves Clinical Remission in Ulcerative Colitis Trial Read Post »
Health TidingsSafusidenib Delivers Long-Term Benefit in Grade 2 IDH1-Mutant Glioma Safusidenib Delivers Long-Term Benefit in Grade 2 IDH1-Mutant Glioma Read Post »
Health TidingsDuvakitug Shows Positive Phase 2b Results in Crohn’s Disease Duvakitug Shows Positive Phase 2b Results in Crohn’s Disease Read Post »
Clinical TrialsTinlarebant Demonstrates Consistent Phase 3 Benefit in Stargardt Disease Tinlarebant Demonstrates Consistent Phase 3 Benefit in Stargardt Disease Read Post »
New Drug ApprovalIndia’s First Approved Dengue Vaccine: CDSCO Clears Takeda’s QD... India’s First Approved Dengue Vaccine: CDSCO Clears Takeda’s QD... Read Post »
Clinical TrialsKolon TissueGene’s TG-C Misses Phase 3 Goals in Knee Osteoarthritis T... Kolon TissueGene’s TG-C Misses Phase 3 Goals in Knee Osteoarthritis T... Read Post »
Health TidingsEMA Accepts GSK’s Bexsero Single-Dose Booster Label Expansion EMA Accepts GSK’s Bexsero Single-Dose Booster Label Expansion Read Post »
Health TidingsPivotal Bexicaserin Trial Completes Randomization in Rare Childhood Epileps... Pivotal Bexicaserin Trial Completes Randomization in Rare Childhood Epileps... Read Post »
ResearchSelective RARβ Agonist KCL-286 Shows Promise in Alzheimer’s Study Selective RARβ Agonist KCL-286 Shows Promise in Alzheimer’s Study Read Post »
